PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
152.55%
Positive growth while JHX shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
152.55%
Positive growth while JHX shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-253.31%
EBITDA decline while JHX shows 139.32% growth. Joel Greenblatt would examine position.
-160.70%
EBITDA margin decline while JHX shows 158.36% growth. Joel Greenblatt would examine position.
-253.31%
Operating income decline while JHX shows 123.19% growth. Joel Greenblatt would examine position.
-160.70%
Operating margin decline while JHX shows 140.95% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-91.58%
Tax expense reduction while JHX shows 78.29% growth. Joel Greenblatt would examine advantage.
91.58%
Net income growth exceeding 1.5x JHX's 43.58%. David Dodd would verify competitive advantages.
-24.14%
Net margin decline while JHX shows 55.00% growth. Joel Greenblatt would examine position.
-100.00%
EPS decline while JHX shows 50.00% growth. Joel Greenblatt would examine position.
-100.00%
Diluted EPS decline while JHX shows 51.06% growth. Joel Greenblatt would examine position.
-100.00%
Both companies reducing share counts. Martin Whitman would check patterns.
-100.00%
Diluted share reduction while JHX shows 0.12% change. Joel Greenblatt would examine strategy.